‘We’ve always been an acquisitions company’: Ebos CEO on firm's future

‘We’ve always been an acquisitions company’: Ebos CEO on firm's future
Ebos CEO John Cullity is looking to other areas after losing the Chemist Warehouse contract. (Image: NZME)
Ella Somers
Ebos is looking to expand as it faces up to life without its $2 billion Chemist Warehouse contract.Although Ebos’ chief executive says the healthcare wholesaler doesn’t give forecasts, there’s one thing he’s certain will remain constant: Ebos will continue to be an acquisitions company.“That's been in the company's DNA even before I joined,” John Cullity told BusinessDesk on Wednesday after the company’s full-year results were released.Cullity has been Ebos’ CEO since 2018 and before...

More Markets

NZX 50 dips despite Fletcher Building's 4.6% gain
Markets Market Close

NZX 50 dips despite Fletcher Building's 4.6% gain

Pacific Edge shares gained after it said it got a step closer to Medicare approval.

ANZ agrees to record A$240m fine for widespread misconduct
Markets

ANZ agrees to record A$240m fine for widespread misconduct

ANZ has agreed to pay the largest penalty its Australian regulator has ever issued an entity in one go, due to failings in the bank’s dealings with both the Government and its retail customers.ANZ and the Australian Securities and Investments Commission (ASIC) will ask the Federa...

Trade Window looks to boost profile with ASX listing
Markets

Trade Window looks to boost profile with ASX listing

Trade Window is moving to broaden its investor base with a secondary listing in Australia.The Auckland-based trade software firm said on Monday that with its secondary listing, it was pursuing "the goal of increasing its profile among the broad pool of investors across the Tasman...

Banks revise economic outlooks for Q2 GDP contraction
Finance

Banks revise economic outlooks for Q2 GDP contraction

Economists now see NZ's GDP contracting in Q2, but doubt a technical recession in Q3.